Suppression of body fat accumulation in myostatin-deficient mice
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Myostatin is a TGF-β family member that acts as a negative regulator of muscle growth. Mice lacking the myostatin gene (Mstn) have a widespread increase in skeletal muscle mass resulting from a combination of muscle fiber hypertrophy and hyperplasia. Here we show that Mstn-null mice have a significant reduction in fat accumulation with increasing age compared with wild-type littermates, even in the setting of normal food intake (relative to body weight), normal body temperature, and a slightly decreased resting metabolic rate. To investigate whether myostatin might be an effective target for suppressing the development of obesity in settings of abnormal fat accumulation, we analyzed the effect of the Mstn mutation in two genetic models of obesity, agouti lethal yellow (Ay) and obese (Lepob/ob). In each case, loss of Mstn led to a partial suppression of fat accumulation and of abnormal glucose metabolism. Our findings raise the possibility that pharmacological agents that block myostatin function may be useful not only for enhancing muscle growth, but also for slowing or preventing the development of obesity and type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Germline deletion of myostatin is viable and in several species shows a benefit not only in increased muscularity, but also in metabolic parameters51,52.”
From GDF8 and activin A blockade protects against GLP-1–induced muscle loss while enhancing fat loss in obese male mice and non-human primates (2025) · cites this paper as [51]
In the citing paper
“For example, myostatin knockout mice [21] or mice in which constitutively active Akt1 is expressed only in skeletal muscle [22] have not only more skeletal muscle mass but also less fat mass and improved glucose homeostasis when compared with wild-type controls.”
From Effects of Skeletal Muscle Hypertrophy on Fat Mass and Glucose Homeostasis in Humans and Animals: A Narrative Review with Systematic Literature Search (2025) · cites this paper as [21]
In the citing paper
“If Mstn is knocked out in a diabetic, overweight mouse strain, then this not only results in muscle hypertrophy but additionally causes profound fat loss and improves glucose homeostasis after a glucose challenge [21].”
From Effects of Skeletal Muscle Hypertrophy on Fat Mass and Glucose Homeostasis in Humans and Animals: A Narrative Review with Systematic Literature Search (2025) · cites this paper as [21]
In the citing paper
“A decrease of circulating myostatin can explain fat loss and improved glucose homeostasis, as this is a phenotype of Mstn−/− mice [21].”
From Effects of Skeletal Muscle Hypertrophy on Fat Mass and Glucose Homeostasis in Humans and Animals: A Narrative Review with Systematic Literature Search (2025) · cites this paper as [21]
Citations
Cites
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Self-citationTGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
Self-citationTowards a molecular understanding of adaptive thermogenesis
Lowell, B. B., & Spiegelman, B. M. (2000) · Nature · doi:10.1038/35007527 · Cited by 1,630
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616
Self-citationA deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice
Coleman, D. L. (1978) · Diabetologia · doi:10.1007/bf00429772 · Cited by 1,307
Research works printed but not linked: 1
- Kahn, 1994, Diabetes, 43, 1066, 10.2337/diabetes.43.4.587 · doi:10.2337/diabetes.43.4.587 · Paper page
Cited by
Items 101–200 of 517
Systemic Nutrient and Stress Signaling via Myokines and Myometabolites
Rai, M., & Demontis, F. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105305 · Cited by 123
Increased bone mineral density in the femora of GDF8 knockout mice
Hamrick, M. W. (2003) · The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology · doi:10.1002/ar.a.10044 · Cited by 121
“GDF8 knockout mice do not differ from normal mice (relative to body weight) in metabolic rate, food consumption, or body temperature (McPherron and Lee, 2002).”
BackgroundInfluentialThe Orphan Nuclear Receptor, NOR-1, Is a Target of β-Adrenergic Signaling in Skeletal Muscle
Pearen, M. A., Ryall, J. G., Maxwell, M. A., Ohkura, N., Lynch, G. S., & Muscat, G. E. O. (2006) · Endocrinology · doi:10.1210/en.2006-0447 · Cited by 120
“Skeletal muscle expresses myostatin, a negative regulator of mass (66–68) that also appears to be a positive regulator of adiposity (68, 69).”
BackgroundSharma, M., McFarlane, C., Kambadur, R., Kukreti, H., Bonala, S., & Srinivasan, S. (2015) · IUBMB Life · doi:10.1002/iub.1392 · Cited by 118
Metabolic benefits of resistance training and fast glycolytic skeletal muscle
LeBrasseur, N. K., Walsh, K., & Arany, Z. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00512.2010 · Cited by 118
“Generation of mice harboring these mutations in the absence of myostatin revealed markedly increased muscle mass that was associated with decreased fat mass accumulation, and improved glycemic control compared with myostatin replete littermates (51).”
BackgroundMolecular bases of the crosstalk between bone and muscle
Karsenty, G., & Mera, P. (2018) · Bone · doi:10.1016/j.bone.2017.04.006 · Cited by 117
“Myostatin-deficient mice show reduced total and intramuscular body fat and improved insulin sensitivity, however and this an important aspect of its biology, myostatin does not improve muscle function [53].”
BackgroundEffects of myostatin deletion in aging mice
Morissette, M. R., Stricker, J. C., Rosenberg, M. A., Buranasombati, C., Levitan, E. B., Mittleman, M. A., & Rosenzweig, A. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00508.x · Cited by 117
“Interestingly, increased muscle mass is also associated with improved glucose and insulin handling and decreased fat mass (Sutrave et al., 1990; Musaro et al., 1999; McPherron & Lee, 2002; Lai et al., 2004; Izumiya et al., 2008).”
BackgroundInfluentialObesity but not high-fat diet impairs lymphatic function
García Nores, G. D., Cuzzone, D. A., Albano, N. J., Hespe, G. E., Kataru, R. P., Torrisi, J. S., Gardenier, J. C., Savetsky, I. L., Aschen, S. Z., Nitti, M. D., et al. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.96 · Cited by 116
“Our results are consistent with previous reports demonstrating that C57BL/6J mice become morbidly obese on HFD feeds,(8, 9) while BALB/cJ and MSTN ln mice do not(21, 22) even though serum FFA levels were significantly increased in all HFD-fed mice.”
Increased Muscle Mass With Myostatin Deficiency Improves Gains in Bone Strength With Exercise
Hamrick, M. W., Samaddar, T., Pennington, C., & McCormick, J. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051203 · Cited by 114
“Myostatin-deficient mice have very little body fat.((36,37)) It is likely that, whereas normal mice used fat reserves as energy sources during exercise, the myostatin-deficient mice were instead forced to use muscle because they had very little body fat at the start of the training regimen.”
BackgroundGuo, W., Flanagan, J., Jasuja, R., Kirkland, J., Jiang, L., & Bhasin, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708968200 · Cited by 115
Johnston, I. A., Manthri, S., Alderson, R., Smart, A., Campbell, P., Nickell, D., Robertson, B., Paxton, C. G. M., & Burt, M. L. (2003) · Journal of Experimental Biology · doi:10.1242/jeb.00262 · Cited by 114
Connecting Myokines and Metabolism
Ahima, R. S., & Park, H.-K. (2015) · Endocrinology and Metabolism · doi:10.3803/enm.2015.30.3.235 · Cited by 108
A Novel Therapeutic Approach to Treating Obesity through Modulation of TGFβ Signaling
Koncarevic, A., Kajimura, S., Cornwall-Brady, M., Andreucci, A., Pullen, A., Sako, D., Kumar, R., Grinberg, A. V., Liharska, K., Ucran, J. A., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1016 · Cited by 109
Characterization and identification of the inhibitory domain of GDF-8 propeptide
Jiang, M., Liang, L., Wang, S., Ratovitski, T., Holmstrom, J., Barker, C., & Stotish, R. L. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.085 · Cited by 119
“085 skeletal muscle mass, Myostatin-null mice have a significant reduction in body fat [3,16].”
BackgroundCalcineurin and skeletal muscle growth
Michel, R. N., Dunn, S. E., & Chin, E. R. (2004) · Proceedings of the Nutrition Society · doi:10.1079/pns2004362 · Cited by 108
“This response may be of therapeutic value, since myostatin inhibition has been shown to play an important role not only in increasing muscle size but also in the prevention of obesity and type 2 diabetes (McPherron & Lee, 2002).”
BackgroundStrength training for obesity prevention in midlife women
Schmitz, K. H., Jensen, M. D., Kugler, K. C., Jeffery, R. W., & Leon, A. S. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802198 · Cited by 119
Myostatin Regulates Energy Homeostasis in the Heart and Prevents Heart Failure
Biesemann, N., Mendler, L., Wietelmann, A., Hermann, S., Schäfers, M. A., Krüger, M., Boettger, T., Borchardt, T., & Braun, T. W. (2014) · Circulation Research · doi:10.1161/circresaha.115.304185 · Cited by 105
Stoikos, C. J., Harrison, C. A., Salamonsen, L. A., & Dimitriadis, E. (2008) · Human Reproduction · doi:10.1093/humrep/den110 · Cited by 112
Novel events in the molecular regulation of muscle mass in critically ill patients
Constantin, D., McCullough, J., Mahajan, R. P., & Greenhaff, P. L. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.206193 · Cited by 100
“5), and may have been in itself, or in combination with the upregulation of myostatin (also shown to inhibit muscle carbohydrate oxidation (McPherron & Lee, 2002), responsible for the reported induction of muscle insulin resistance typical of critical illness (Robinson & van Soeren, 2004).”
BackgroundDepletion of Myostatin b Promotes Somatic Growth and Lipid Metabolism in Zebrafish
Gao, Y., Dai, Z., Shi, C., Zhai, G., Jin, X., He, J., Lou, Q., & Yin, Z. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00088 · Cited by 112
“Myostatin depletion leads to the suppression of body fat accumulation resulting in lean mice (7).”
BackgroundKim, J.-S., Petrella, J. K., Cross, J. M., & Bamman, M. M. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01194.2006 · Cited by 100
“In addition, myostatin appears to profoundly influence adipocyte metabolism (32, 57).”
Effects of the myostatin F94L substitution on beef traits1
Esmailizadeh, A., Bottema, C. D. K., Sellick, G. S., Verbyla, A. P., Morris, C. A., Cullen, N. G., & Pitchford, W. S. (2008) · Journal of Animal Science · doi:10.2527/jas.2007-0589 · Cited by 119
“This finding is consistent with some previous reports on myostatin effects (Menissier, 1982; Hanset, 1991), but heavier weights at birth have been documented in many studies in which double-muscling gene knockout mutations were involved (Nott and Rollins, 1979; Arthur et al., 1989; Arthur, 1995;…”
Lipina, C., Kendall, H., McPherron, A. C., Taylor, P. M., & Hundal, H. S. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.04.039 · Cited by 95
“Therefore, interestingly, our data suggests that loss of myostatin function leads to a fibre type distribution more characteristic of an insulin resistant state, despite myostatin-deficient mice displaying increased insulin sensitivity and resistance to diet-induced obesity [48,51,53].”
BackgroundSelf-citationSerum Myostatin is Upregulated in Obesity and Correlates with Insulin Resistance in Humans
Amor, M., Itariu, B. K., Moreno-Viedma, V., Keindl, M., Jürets, A., Prager, G., Langer, F., Grablowitz, V., Zeyda, M., & Stulnig, T. M. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0641-5546 · Cited by 93
Myofibrillar protein synthesis in myostatin-deficient mice
Welle, S., Bhatt, K., & Pinkert, C. A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2005 · Cited by 93
“Protein synthesis requires considerable energy (20), and the energy required to maintain even a normal rate of protein synthesis in the enormous muscles of myostatin-deficient mice could be a major component of their elevated metabolic rate (9).”
BackgroundThe Orphan Rev-Erb Nuclear Receptors: A Link between Metabolism, Circadian Rhythm and Inflammation?
Ramakrishnan, S. N., & Muscat, G. E. O. (2006) · Nuclear Receptor Signaling · doi:10.1621/nrs.04009 · Cited by 94
Sciorati, C., Clementi, E., Manfredi, A. A., & Rovere, P. Q. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1857-7 · Cited by 107
“Its expression in mesenchymal cells promotes its adipogenic differentiation via Smad3 with a negative cross talk with b catenin [170, 171].”
BackgroundChen, Y., Ye, J., Cao, L., Zhang, Y., Xia, W., & Zhu, D. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.09.017 · Cited by 104
Interleukin-15: A muscle-derived cytokine regulating fat-to-lean body composition1,2
Quinn, L. S. (2008) · Journal of Animal Science · doi:10.2527/jas.2007-0458 · Cited by 91
Myostatin inhibits differentiation of bovine preadipocyte
Hirai, S., Matsumoto, H., Hino, N., Kawachi, H., Matsui, T., & Yano, H. (2005) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2005.12.001 · Cited by 92
“It is not clarified how myostatin regulates postnatal fat accumulation, however, unphysiological condition such as lack of myostatin may affect energy metabolism and prevent fat accumulation elsewhere in the body [22].”
BackgroundRev-erbβ Regulates the Expression of Genes Involved in Lipid Absorption in Skeletal Muscle Cells
Ramakrishnan, S. N., Lau, P., Burke, L. J., & Muscat, G. E. O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413949200 · Cited by 89
Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency
Gautam, D., Gavrilova, O., Jeon, J., Pack, S., Jou, W., Cui, Y., Li, J. H., & Wess, J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.09.008 · Cited by 99
Role of myostatin in metabolism
Gonzalez-Cadavid, N. F., & Bhasin, S. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000134365.99523.7f · Cited by 88
Myostatin Inhibitors: Panacea or Predicament for Musculoskeletal Disorders?
Suh, J., & Lee, Y. (2020) · Journal of Bone Metabolism · doi:10.11005/jbm.2020.27.3.151 · Cited by 104
“Indeed, myostatin deficient mice exhibit reduced total body fat in addition to increased muscle mass, and loss of myostatin partially prevented fat accumulation and abnormal glucose metabolism in mouse models of obesity and type 2 diabetes.[27] Also, circulating myostatin levels were reported to be higher in obese hum…”
BackgroundMyostatin: a skeletal muscle chalone
Lee, S.-J. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012422-112116 · Cited by 84
Self-citationTGFβ signaling: its role in fibrosis formation and myopathies
MacDonald, E. M., & Cohn, R. D. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328358df34 · Cited by 84
“When myostatin knockout mice are crossed to genetic models of obesity, such as the leptin-deficient model, they are protected from obesity [45].”
Hjorth, M., Pourteymour, S., Görgens, S. W., Langleite, T. M., Lee, S., Holen, T., Gulseth, H. L., Birkeland, K. I., Jensen, J., Drevon, C. A., et al. (2016) · Acta Physiologica · doi:10.1111/apha.12631 · Cited by 83
Self-citationSchneyer, A. L., Sidis, Y., Gulati, A., Sun, J. L., Keutmann, H., & Krasney, P. A. (2008) · Endocrinology · doi:10.1210/en.2008-0259 · Cited by 83
“In addition, myostatin influences adipogenesis because both overexpression and genetic disruption of myostatin expression result in reduced fat mass (10).”
BackgroundRosiglitazone modifies the adipogenic potential of human muscle satellite cells
De Coppi, P., Milan, G., Scarda, A., Boldrin, L., Centobene, C., Piccoli, M., Pozzobon, M., Pilon, C., Pagano, C., Gamba, P., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0304-6 · Cited by 81
“Moreover, loss of myostatin reduces body fat accumulation [18], although other studies reported that myostatin treatment reduces fat mass in vivo [19] and inhibits 3T3-L1 adipogenic differentiation by decreasing PPARG expression [19, 20].”
The new frontier in muscular dystrophy research: booster genes
Engvall, E., & Wewer, U. M. (2003) · The FASEB Journal · doi:10.1096/fj.02-1215rev · Cited by 91
“Animals with mutations in the myostatin gene have both muscle hyperplasia and hypertrophy and less fat and connective tissue in muscle (33).”
BackgroundEating Behavior Disorders in Uremia: A Question of Balance in Appetite Regulation
Aguilera, A., Codoceo, R., Bajo, M. A., Iglesias, P., Díez, J. J., Barril, G., Cigarrán, S., Álvarez, V., Celadilla, O., Perpen, A. C. F., et al. (2004) · Seminars in Dialysis · doi:10.1046/j.0894-0959.2004.16086.x · Cited by 87
Myostatin – The Holy Grail for Muscle, Bone, and Fat?
Buehring, B., & Binkley, N. (2013) · Current Osteoporosis Reports · doi:10.1007/s11914-013-0160-5 · Cited by 79
“McPherron and Lee noted in their initial publications that myostatin deficient mice had reduced amounts of subcutaneous adipose tissue and that myostatin RNA could be isolated in adipocytes [20, 57].”
BackgroundMyonectin deletion promotes adipose fat storage and reduces liver steatosis
Little, H. C., Rodriguez, S., Lei, X., Tan, S. Y., Stewart, A. N., Sahagun, A., Sarver, D. C., & William Wong, G. (2019) · The FASEB Journal · doi:10.1096/fj.201900520r · Cited by 78
Bone architecture and disc degeneration in the lumbar spine of mice lacking GDF‐8 (myostatin)
Hamrick, M. W., Pennington, C., & Byron, C. D. (2003) · Journal of Orthopaedic Research · doi:10.1016/s0736-0266(03)00105-0 · Cited by 78
Price, E. R., Bauchinger, U., Zajac, D. M., Cerasale, D. J., McFarlan, J. T., Gerson, A. R., McWilliams, S. R., & Guglielmo, C. G. (2011) · Journal of Experimental Biology · doi:10.1242/jeb.057620 · Cited by 89
Myostatin: a modulator of skeletal-muscle stem cells
Walsh, F. S., & Celeste, A. J. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331513 · Cited by 77
Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice
Sumner, C. J., Wee, C. D., Warsing, L. C., Choe, D. W., Ng, A. S., Lutz, C. M., & Wagner, K. R. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp253 · Cited by 84
“Myostatin is expressed in adipose tissue and it has been previously reported that adult myostatin null mice are lean with an estimated 70% reduction in total fat stores (51).”
BackgroundHan, X., Møller, L. L. V., De Groote, E., Bojsen‐Møller, K. N., Davey, J., Henríquez‐Olguin, C., Li, Z., Knudsen, J. R., Jensen, T. E., Madsbad, S., et al. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12474 · Cited by 75
Regulation of Long Bone Growth in Vertebrates; It Is Time to Catch Up
Roselló‐Díez, A., & Joyner, A. L. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1048 · Cited by 119
“Of note, however, these molecules do not strictly adhere to the chalone definition, for example concerning tissue specificity (27, 28).”
BackgroundRyan, A. S., Li, G., Blumenthal, J. B., & Ortmeyer, H. K. (2013) · Obesity · doi:10.1002/oby.20216 · Cited by 72
“Agouti lethal yellow and obese (Lep) myostatin knock-out mice have a reduction in body fat and improved glucose tolerance (16).”
BackgroundTu, P., Bhasin, S., Hruz, P. W., Herbst, K. L., Castellani, L. W., Hua, N., Hamilton, J. A., & Guo, W. (2009) · Diabetes · doi:10.2337/db09-0349 · Cited by 72
“Disruption of myostatin gene has also been shown to prevent the development of obesity (6).”
Koncarevic, A., Cornwall-Brady, M., Pullen, A., Davies, M., Sako, D., Liu, J., Kumar, R., Tomkinson, K., Baker, T., Umiker, B., et al. (2010) · Endocrinology · doi:10.1210/en.2010-0134 · Cited by 71
Regulation of brown adipocyte metabolism by myostatin/follistatin signaling
Singh, R., Braga, M., & Pervin, S. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00060 · Cited by 70
“…increase in skeletal muscle mass. Initial phenotypic characterization of Mst-deficient mice revealed suppression of body fat accumulation, an unexpected finding that suggested a possible role of Mst in the control of energy balance beyond its effect on skeletal muscle (McPherron and Lee, 2002).”
BackgroundCellular mechanisms and local progenitor activation to regulate skeletal muscle mass
Cassano, M., Quattrocelli, M., Crippa, S., Perini, I., Ronzoni, F., & Sampaolesi, M. (2009) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-010-9204-y · Cited by 77
“…of early and late adipogenic markers, and this is consistent with the observation in myostatin-null mice, where serum leptin levels were strongly decreased with a age-dependent reduction of the total fat body mass, up to 70% in 32 weeks old mice (McPherron and Lee 2002; Artaza et al. 2005).”
ResultBernardo, B. L., Wachtmann, T. S., Cosgrove, P. G., Kuhn, M., Opsahl, A. C., Judkins, K. M., Freeman, T. B., Hadcock, J. R., & LeBrasseur, N. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011307 · Cited by 69
“Similar to resistance training, conditional expression of a constitutively active Akt1-transgene [16], transgenic deletion of myostatin [15,25], and expression of a dominant negative ActRIIb receptor in skeletal muscle [25], PF-879 robustly increased skeletal muscle mass and improved glucose homeostasis and tolerance…”
BackgroundResultInfluentialMuscle Hyperplasia in Japanese Quail by Single Amino Acid Deletion in MSTN Propeptide
Lee, J., Kim, D., & Lee, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041504 · Cited by 76
“MSTN mutation resulted in decreased fat mass in mice [46,47], cattle [48,49], and pigs [50].”
BackgroundKinouchi, N., Ohsawa, Y., Ishimaru, N., Ohuchi, H., Sunada, Y., Hayashi, Y., Tanimoto, Y., Moriyama, K., & Noji, S. (2008) · Gene Therapy · doi:10.1038/gt.2008.24 · Cited by 68
Increased Muscle Force Production and Bone Mineral Density in ActRIIB-Fc-Treated Mature Rodents
Chiu, C.-S., Peekhaus, N., Weber, H., Adamski, S., Murray, E. M., Zhang, H. Z., Zhao, J. Z., Ernst, R., Lineberger, J., Huang, L., et al. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt030 · Cited by 68
“The quantitative nuclear magnetic resonance data showed no obvious change in body weight for any group; however, the 10 and 30 mg/kg groups had significant increases in total lean mass and a trend toward a decrease in total fat mass (Table 1) reminiscent of findings in myostatin deficiency (31).”
BackgroundMyostatin: Basic biology to clinical application
Esposito, P. B., Picciotto, D., Battaglia, Y., Costigliolo, F., Viazzi, F. C., & Verzola, D. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2021.09.006 · Cited by 83
Myostatin signals through miR-34a to regulate Fndc5 expression and browning of white adipocytes
Ge, X., Sathiakumar, D., Lua, B. J. G., Kukreti, H., Lee, M., & McFarlane, C. (2017) · International Journal of Obesity · doi:10.1038/ijo.2016.110 · Cited by 66
Rybalka, E., Timpani, C. A., Debruin, D. A., Bagaric, R. M., Campelj, D. G., & Hayes, A. (2020) · Cells · doi:10.3390/cells9122657 · Cited by 73
Myostatin Is a Human Placental Product That Regulates Glucose Uptake
Mitchell, M. D., Osepchook, C. C., Leung, K.-C., McMahon, C. D., & Bass, J. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2361 · Cited by 67
Resistance to body fat gain in ‘double-muscled’ mice fed a high-fat diet
Hamrick, M. W., Pennington, C., Webb, C. N., & Isales, C. M. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803200 · Cited by 66
Reduction of ribosome biogenesis with activation of the mTOR pathway in denervated atrophic muscle
Machida, M., Takeda, K., Yokono, H., Ikemune, S., Taniguchi, Y., Kiyosawa, H., & Takemasa, T. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22871 · Cited by 65
“As previous studies showed that dogs (Shelton and Engvall, 2007), mice (McPherron and Lee, 2002), and humans (Schuelke et al., 2004) with innate myostatin deficiency had a larger muscle mass, myostatin is now recognized to be a negative regulator of skeletal muscle hypertrophy.”
The callipyge mutation and other genes that affect muscle hypertrophy in sheep
Cockett, N., Smit, M. A., Bidwell, C. A., Segers, K., Hadfield, T., Snowder, G. D., Georges, M., & Charlier, C. (2004) · Genetics Selection Evolution · doi:10.1051/gse:2004032 · Cited by 68
Li, Z., Shelton, G. D., & Engvall, E. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62271-7 · Cited by 74
Braga, M., Pervin, S., Norris, K., Bhasin, S., & Singh, R. (2013) · Obesity · doi:10.1002/oby.20117 · Cited by 64
“Mst has emerged as an important regulator of muscle mass as well as overall fat content in mice (1-4).”
BackgroundPeripheral signalling involved in energy homeostasis control
Lancha, A., Frühbeck, G., & Gómez‐Ambrosi, J. (2012) · Nutrition Research Reviews · doi:10.1017/s0954422412000145 · Cited by 76
“As can be expected, mice lacking myostatin exhibit increased muscle mass but, surprisingly, show reduced adiposity((405)).”
BackgroundEmerging roles for the TGFβ family in pancreatic β-cell homeostasis
Brown, M. L., & Schneyer, A. L. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.02.008 · Cited by 63
Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications
Coleman, S. K., Rebalka, I. A., D'Souza, D. M., & Hawke, T. J. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i17.1323 · Cited by 72
Kemp, J. G., Blazev, R., Stephenson, D. G., & Stephenson, G. M. M. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.100 · Cited by 63
Sprinting without myostatin: a genetic determinant of athletic prowess
Lee, S. (2007) · Trends in Genetics · doi:10.1016/j.tig.2007.08.008 · Cited by 69
“mutations in mice also exhibit a dose-dependent effect, with homozygotes having about a doubling of muscle weights and heterozygotes having a � 25% increase in muscle weights [ 11 ].”
BackgroundSelf-citationActivin Signaling: Effects on Body Composition and Mitochondrial Energy Metabolism
Li, L., Shen, J. J., Bournat, J. C., Huang, L., Chattopadhyay, A., Li, Z., Shaw, C., Graham, B. H., & Brown, C. W. (2009) · Endocrinology · doi:10.1210/en.2008-0922 · Cited by 61
Myokines as possible therapeutic targets in cancer cachexia
Manole, E., Ceafalan, L. C., Popescu, B. O., Dumitru, C., & Bastian, A. E. (2018) · Journal of Immunology Research · doi:10.1155/2018/8260742 · Cited by 60
“Myostatin null mice develop a massive muscular hypertrophy resulting from an accelerated myogenesis [21, 36], accompanied by a massive reduction in fatty tissue [30].”
Lee, S.-J., Lehar, A., Liu, Y., Ly, C. H., Pham, Q.-M., Michaud, M., Rydzik, R., Youngstrom, D. W., Shen, M. M., Kaartinen, V., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019263117 · Cited by 59
Self-citationAllen, D. L., Cleary, A. S., Lindsay, S. F., Loh, A. S., & Reed, J. M. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00504.2010 · Cited by 59
“We observed no significant difference in blood glucose levels between wild-type and MSTN-null mice for either the fed or 1-day fasted conditions, similar to what has been reported previously (16, 38).”
Konopka, A. R., Wolff, C. A., Suer, M. K., & Harber, M. P. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00030.2018 · Cited by 59
Liu, X.-H., Bauman, W. A., & Cardozo, C. P. (2018) · Physiological Reports · doi:10.14814/phy2.13837 · Cited by 59
Muscle regeneration through myostatin inhibition
Wagner, K. R. (2005) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000184163.61558.ca · Cited by 65
Myokines: Metabolic regulation in obesity and type 2 diabetes
Chen, Z.-T., Weng, Z.-X., Lin, J. D., & Meng, Z.-X. (2024) · Life Metabolism · doi:10.1093/lifemeta/loae006 · Cited by 58
“However, another study found that Mstn loss in mice results in lower rates of total and resting O 2 consumption compared with the control group [122].”
Castillero, E., Nieto-Bona, M. P., Fernández-Galaz, C., Martín, A. I., López-Menduiña, M., Granado, M., Villanúa, M. A., & López-Calderón, A. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00590.2010 · Cited by 58
“In addition, myostatin-deficient mice exhibit markedly increased muscle mass composed mainly of fast fibers (38).”
BackgroundMyostatin: a therapeutic target for skeletal muscle wasting
Roth, S. M., & Walsh, S. (2004) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200405000-00004 · Cited by 58
Myostatin inhibitors as pharmacological treatment for muscle wasting and muscular dystrophy
Saitoh, M., Ishida, J., Ebner, N., Anker, S. D., Springer, J., & von Haehling, S. (2017) · JCSM Clinical Reports · doi:10.17987/jcsm-cr.v2i1.37 · Cited by 57
Novel insights into the complex architecture of osteoporosis molecular genetics
Saad, F. A. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14231 · Cited by 58
Adaptive Plasticity in the Mammalian Masticatory Complex: You AreWhat, and How, You Eat
Ravosa, M. J., López, E. K. N., Menegaz, R. A., Stock, S. R., Stack, M. S., & Hamrick, M. W. (2008) · Springer eBooks · doi:10.1007/978-0-387-76585-3_14 · Cited by 56
Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis
Brown, M. L., Bonomi, L., Ungerleider, N., Zina, J., Kimura, F., Mukherjee, A., Sidis, Y., & Schneyer, A. (2011) · Obesity · doi:10.1038/oby.2011.97 · Cited by 55
“Myostatin regulates both muscle and fat mass and also modulates glucose homeostasis (4,10,11).”
BackgroundGarcía-Fontana, B., Reyes‐García, R., Morales, S., Ávila-Rubio, V., Muñoz‐Garach, A., Rozas-Moreno, P., & Muñoz‐Torres, M. (2015) · Endocrine · doi:10.1007/s12020-015-0758-8 · Cited by 64
Cleasby, M. E., Jarmin, S., Eilers, W., Elashry, M., Andersen, D. K., Dickson, G., & Foster, K. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00586.2013 · Cited by 55
Walker, C. G., Littlejohn, M. D., Mitchell, M. D., Roche, J. R., & Meier, S. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00254.2010 · Cited by 75
Biomineralization and adaptive plasticity of the temporomandibular joint in myostatin knockout mice
Nicholson, E. K., Stock, S. R., Hamrick, M. W., & Ravosa, M. J. (2005) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2005.05.008 · Cited by 56
Mastaitis, J. W., Gomez, D., Raya, J. G., Li, D., Min, S., Stec, M., Kleiner, S., McWilliams, T., Altarejos, J. Y., Murphy, A. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59485-9 · Cited by 53
“Germline deletion of myostatin is viable and in several species shows a bene fi t not only in increased muscularity, but also in metabolic parameters 51,52 .”
AMPK activation by AICAR inhibits myogenic differentiation and myostatin expression in Cattle
Miyake, M., Takahashi, H., Kitagawa, E., Watanabe, H., Sakurada, T., Aso, H., & Yamaguchi, T. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1422-8 · Cited by 51
Delogu, W., Caligiuri, A., Provenzano, A., Rosso, C., Bugianesi, E., Coratti, A., Macias-Barragan, J., Galastri, S., Di Maira, G., & Marra, F. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.03.002 · Cited by 51
“Myostatin-deficient mice have a significant reduction in fat accumulation,despite normal food intake, and show improved insulin sensitiv-ity in conditions of obesity [5,6].”
BackgroundRyan, A. S., & Li, G. (2021) · JCSM Clinical Reports · doi:10.1002/crt2.43 · Cited by 51
“In a preclinical study that compared the myostatin-null mice with wild-type littermates, the former had a significant reduction in fat accumulation with increasing age.(34) Myostatin deletion or inhibition leads to a decrease in fat mass in mice.”
BackgroundDysregulation of Lymphatic Endothelial VEGFR3 Signaling in Disease
Kuonqui, K. G., Campbell, A.-C., Sarker, A., Roberts, A., Pollack, B. L., Park, H. J., Shin, J., Brown, S., Mehrara, B. J., & Kataru, R. P. (2023) · Cells · doi:10.3390/cells13010068 · Cited by 57
“Analyzing sorted LECs from HFD-fed C57BL/6J obesity-prone mice showed that the expression of VEGFR3 is decreased in obesity, while HFD-fed BALB/cJ and myostatin null ( MSTN ln ) obesity-resistant mice had no significant changes to their lymphatics [159–161].”
BackgroundEquine performance genes and the future of doping in horseracing
Wilkin, T., Baoutina, A., & Hamilton, N. A. (2017) · Drug Testing and Analysis · doi:10.1002/dta.2198 · Cited by 55
“Similar double-muscled phenotypes have been seen in mice,([40]) cattle,([41]) sheep([42]) and humans.”
BackgroundMyotonic Dystrophy: Therapeutic Strategies for the Future
Wheeler, T. M. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.08.001 · Cited by 62
Tobin, J. F., & Celeste, A. J. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.03.016 · Cited by 50
Brandt, C., Hansen, R. H., Hansen, J. B., Olsen, C. H., Galle, P., Mandrup-Poulsen, T. R., Gehl, J., Pedersen, B. K., & Højman, P. (2014) · Metabolism · doi:10.1016/j.metabol.2014.10.007 · Cited by 54
Nascimento, E. B., Osler, M. E., & Zierath, J. R. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00212.2013 · Cited by 49
Metadata
- Authors
- McPherron, A. C., & Lee, S.-J.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Lee, Se-Jin
- Venue
- Journal of Clinical Investigation
- Published
- 2002-03-01
- Volume
- 109
- Issue
- 5
- Pages
- 595-601
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4239540302
- Cited by
- 505
- References
- 31
- Citations by year
- 2026: 15 · 2025: 10 · 2024: 17 · 2023: 18 · 2022: 21 · 2021: 16 · 2020: 32 · 2019: 24 · 2018: 19 · 2017: 18 · 2016: 22 · 2015: 27 · 2014: 31 · 2013: 20 · 2012: 21
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- myostatin, Mstn knockout mice, fat deposition, obesity, type 2 diabetes, glucose metabolism, skeletal muscle hypertrophy, muscle hyperplasia, obese mice, TGF-beta superfamily
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.